Abstract:Patients generally prefer a simple linear representation of group mean HRQL scores, and can accurately interpret data presented in this format more than 98% of the time irrespective of their age group and educational level. The findings have important implications for the communication of clinical trial HRQL results.
“…It is possible that HRQL data are more informative in surgical oncology trials where resection of the primary tumour, local nodes and surrounding tissues with or without reconstruction has an immediate negative impact on HRQL as well as relieving specific symptoms related to the primary tumour 26 . Where there is clinical equipoise, it is more likely that HRQL aspects will influence treatment choice, although the practicalities of imparting HRQL information to patients alongside survival and other clinical outcome data are complex 27 . Further work is needed in this area to develop best methods of explaining HRQL outcomes to patients.…”
The negative treatment-related impact of chemoradiation on short-term HRQL is less than that experienced with combination treatment including surgery. Patients preferring early recovery should consider definitive chemoradiation.
“…It is possible that HRQL data are more informative in surgical oncology trials where resection of the primary tumour, local nodes and surrounding tissues with or without reconstruction has an immediate negative impact on HRQL as well as relieving specific symptoms related to the primary tumour 26 . Where there is clinical equipoise, it is more likely that HRQL aspects will influence treatment choice, although the practicalities of imparting HRQL information to patients alongside survival and other clinical outcome data are complex 27 . Further work is needed in this area to develop best methods of explaining HRQL outcomes to patients.…”
The negative treatment-related impact of chemoradiation on short-term HRQL is less than that experienced with combination treatment including surgery. Patients preferring early recovery should consider definitive chemoradiation.
“…Recently, different ways of communicating HRQL to patients with lung cancer have been tested. It was found that most patients understand simple graphical presentations of mean quality-of-life scores [17]. More work is needed to train surgeons to understand and communicate HRQL and clinical outcomes to patients.…”
“…Patients want information about the impact of treatment options on their HRQoL when making decisions about treatment [38,39] and are capable of interpreting HRQoL data when presented in simple formats [40]. When HRQoL data are presented to them in the decision-making process, it has been shown to influence their decisions about treatment options [41].…”
Future research needs to identify ways in with PROs can be better incorporated into the routine care of patients by combining qualitative and quantitative methods and adopting appropriate trial designs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.